Krowka JF - Search Results

1

Immunological characteristics of the putative CD4-binding site of the HIV-1 envelope protein.

Kieber-Emmons T, Krowka JF, Boyer J, Ugen KE, Williams WV, Morrow WJ, Weiner DB. Kieber-Emmons T, et al. Among authors: krowka jf. Pathobiology. 1992;60(4):187-94. doi: 10.1159/000163722. Pathobiology. 1992. PMID: 1388715

2

Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment.

Morrow WJ, Homsy J, Eichberg JW, Krowka J, Pan LZ, Gaston I, Legg H, Lerche N, Thomas J, Levy JA. Morrow WJ, et al. AIDS Res Hum Retroviruses. 1989 Apr;5(2):233-45. doi: 10.1089/aid.1989.5.233. AIDS Res Hum Retroviruses. 1989. PMID: 2713168

3

The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro.

Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ. Shalaby MR, et al. Among authors: krowka jf. Cell Immunol. 1987 Nov;110(1):140-8. doi: 10.1016/0008-8749(87)90108-0. Cell Immunol. 1987. PMID: 2824064

4

Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.

Krowka J, Stites D, Mills J, Hollander H, McHugh T, Busch M, Wilhelm L, Blackwood L. Krowka J, et al. Clin Exp Immunol. 1988 May;72(2):179-85. Clin Exp Immunol. 1988. PMID: 2842093 Free PMC article.

5

Epitopes of human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins recognized by antibodies in the sera of HIV-1-infected individuals.

Krowka JF, Singh B, Stites DP, Maino VC, Narindray D, Hollander H, Jain S, Chen H, Blackwood L, Steimer KS. Krowka JF, et al. Clin Immunol Immunopathol. 1991 Apr;59(1):53-64. doi: 10.1016/0090-1229(91)90081-k. Clin Immunol Immunopathol. 1991. PMID: 1708316

6

Monocyte-mediated lysis of HIV-infected tumor cells.

Debs RJ, Krowka J, Stites D, Brunette EN, Düzgünes N, Philip R. Debs RJ, et al. AIDS Res Hum Retroviruses. 1990 Aug;6(8):1005-9. doi: 10.1089/aid.1990.6.1005. AIDS Res Hum Retroviruses. 1990. PMID: 1699572

7

Lymphocyte proliferative responses to soluble and liposome-conjugated envelope peptides of HIV-1.

Krowka J, Stites D, Debs R, Larsen C, Fedor J, Brunette E, Düzgünes N. Krowka J, et al. J Immunol. 1990 Apr 1;144(7):2535-40. J Immunol. 1990. PMID: 1969450

8

Lack of associations of chemotactic cytokines with viral burden, disease progression, or lymphocyte subsets in HIV-infected individuals.

Krowka JF, Gesner ML, Ascher MS, Sheppard HW. Krowka JF, et al. Clin Immunol Immunopathol. 1997 Oct;85(1):21-7. doi: 10.1006/clin.1997.4411. Clin Immunol Immunopathol. 1997. PMID: 9325065

9

Expression of CD69 after in vitro stimulation: a rapid method for quantitating impaired lymphocyte responses in HIV-infected individuals.

Krowka JF, Cuevas B, Maron DC, Steimer KS, Ascher MS, Sheppard HW. Krowka JF, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):95-104. doi: 10.1097/00042560-199601010-00013. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8528739

10

Immunological effects of HIV infection.

Krowka JF, Moody DJ, Stites DP. Krowka JF, et al. Immunol Ser. 1989;44:257-303. Immunol Ser. 1989. PMID: 2535143 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters